To investigate factors predicting the onset of major adverse cardiovascular and
cerebrovascular events (MACCEs) after primary percutaneous coronary intervention (pPCI) …

Aim To evaluate a correlation of serum level of neutrophil gelatinase-associated lipocalin
(NGAL) to the risk of the occurrence of complications in patients with the early phase of ST …

Background There are no previous data on serial changes in neutrophil gelatinase-
associated lipocalin (NGAL) levels in ST-segment elevation myocardial infarction (STEMI) …

Objectives Neutrophil gelatinase-associated lipocalin (NGAL) from a pathophysiological
perspective connects various pathways that affect the prognosis after myocardial infarction …

Objectives: The aim of this study was to investigate the prognostic role of neutrophil
gelatinase–associated lipocalin (NGAL) in a large population of patients with ST-segment …

We aimed to assess the clinical significance of serum levels of neutrophil gelatinase-
associated lipocalin (sNGAL) for predicting in-hospital outcomes in patients with ST …

Background: Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are
new systemic inflammation markers and predictor of adverse cardiovascular outcomes …

Acute myocardial infarction (AMI) remains a lifethreatening disease worldwide. Among AMI
patients who survive, 20% suffer a second cardiovascular event within the first year. 1 …

Background Inflammatory biomarkers are known to rise and have predictive value for
adverse outcomes in patients with acute coronary ischemia. One of those biomarkers is …

Background Circulating neutrophil gelatinase-associated lipocalin (NGAL) concentration
increases in cardiovascular disease, but the long-term prognostic value of NGAL …